Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

MAFT is a reliable method for forehead contouring with high patient satisfaction and long-term results.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Women with pattern hair loss may have more stress in their bodies due to a lack of NRF2, a protein. Eating healthy and losing weight could help reduce this stress and improve hair loss. NRF2 boosters might also help treat this type of hair loss.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Act quickly to prevent permanent hair loss from tight hairstyles.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

The flaky skin mouse mutation is a natural model for studying human psoriasis.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Using finasteride with TIP extends time off period for prostate cancer patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.

Gefitinib therapy can cause unusual hair growth on the nose.

A20 protein is crucial for normal skin and hair development.

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

An 8-year-old boy with hair-pulling disorder had a bald patch that was confirmed not to be a fungal infection and was treated with therapy.

TGF-β and FGF pathways are crucial for skin development and regeneration.